Zhang, ChuanJie et al. “Methionine secreted by tumor-associated pericytes supports cancer stem cells in clear cell renal carcinoma.” Cell metabolism vol. 36,4 (2024): 778-792.e10. doi:10.1016/j.cmet.2024.01.018

Long, Alan W et al. “Heterodimerization of T cell engaging bispecific antibodies to enhance specificity against pancreatic ductal adenocarcinoma.” Journal of hematology & oncology vol. 17,1 20. 23 Apr. 2024, doi:10.1186/s13045-024-01538-5

Long, Alan W et al. “Heterodimerization of T cell engaging bispecific antibodies to enhance specificity against pancreatic ductal adenocarcinoma.” Journal of hematology & oncology vol. 17,1 20. 23 Apr. 2024, doi:10.1186/s13045-024-01538-5

Long, Alan W et al. “Heterodimerization of T cell engaging bispecific antibodies to enhance specificity against pancreatic ductal adenocarcinoma.” Journal of hematology & oncology vol. 17,1 20. 23 Apr. 2024, doi:10.1186/s13045-024-01538-5

Lee, Eugine et al. “Timing of treatment shapes the path to androgen receptor signaling inhibitor resistance in prostate cancer.” bioRxiv : the preprint server for biology 2024.03.18.585532. 20 Mar. 2024, doi:10.1101/2024.03.18.585532. Preprint.

Chen, Jenny Ling-Yu et al. “Cisplatin and Albumin-Based Gold-Cisplatin Nanoparticles Enhance Ablative Radiation Therapy-Induced Antitumor Immunity in Local and Distant Tumor Microenvironment.” International journal of radiation oncology, biology, physics vol. 116,5 (2023): 1135-1149. doi:10.1016/j.ijrobp.2023.02.014

Chen, Jenny Ling-Yu et al. “Therapeutic efficacy of cyclin-dependent kinase inhibition in combination with ionizing radiation for lung cancer.” International journal of radiation biology vol. 99,8 (2023): 1257-1266. doi:10.1080/09553002.2023.2161658

Yang, Long et al. “M2 macrophage inhibits the antitumor effects of Lenvatinib on intrahepatic cholangiocarcinoma.” Frontiers in immunology vol. 14 1251648. 22 Sep. 2023, doi:10.3389/fimmu.2023.1251648

Park, Jeong A et al. “Targeting tumor vasculature to improve antitumor activity of T cells armed ex vivo with T cell engaging bispecific antibody.” Journal for immunotherapy of cancer vol. 11,3 (2023): e006680. doi:10.1136/jitc-2023-006680

Huang, Feng-Ying et al. “3'-epi-12β-hydroxyfroside-mediated autophagy degradation of RIPK1/RIPK3 necrosomes leads to anergy of immunogenic cell death in triple-negative breast cancer cells.” Pharmacological research vol. 187 (2023): 106613. doi:10.1016/j.phrs.2022.106613

Wang, Cheng-Kai et al. “MEX3A Mediates p53 Degradation to Suppress Ferroptosis and Facilitate Ovarian Cancer Tumorigenesis.” Cancer research vol. 83,2 (2023): 251-263. doi:10.1158/0008-5472.CAN-22-1159

Liu, Rangru et al. “A Novel PDK1/MEK Dual Inhibitor Induces Cytoprotective Autophagy via the PDK1/Akt Signaling Pathway in Non-Small Cell Lung Cancer.” Pharmaceuticals (Basel, Switzerland) vol. 16,2 244. 6 Feb. 2023, doi:10.3390/ph16020244

Wu, Ching-Feng et al. “The anticancer effects of cyanidin 3-O-glucoside combined with 5-fluorouracil on lung large-cell carcinoma in nude mice.” Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie vol. 151 (2022): 113128. doi:10.1016/j.biopha.2022.113128

Grochowska, Aleksandra et al. “Evidence supporting the oncogenic role of BAZ1B in colorectal cancer.” American journal of cancer research vol. 12,10 4751-4763. 15 Oct. 2022

Wang, Jin-Yan et al. “Immunotherapy combining tumor and endothelium cell lysis with immune enforcement by recombinant MIP-3α Newcastle disease virus in a vessel-targeting liposome enhances antitumor immunity.” Journal for immunotherapy of cancer vol. 10,3 (2022): e003950. doi:10.1136/jitc-2021-003950

Wang, Hua et al. “Posaconazole inhibits the stemness of cancer stem-like cells by inducing autophagy and suppressing the Wnt/β-catenin/survivin signaling pathway in glioblastoma.” Frontiers in pharmacology vol. 13 905082. 11 Aug. 2022, doi:10.3389/fphar.2022.905082

Park, Jeong A, and Nai-Kong V Cheung. “Overcoming tumor heterogeneity by ex vivo arming of T cells using multiple bispecific antibodies.” Journal for immunotherapy of cancer vol. 10,1 (2022): e003771. doi:10.1136/jitc-2021-003771

Choi, Seo-Hyun et al. “KRAS Mutants Upregulate Integrin β4 to Promote Invasion and Metastasis in Colorectal Cancer.” Molecular cancer research : MCR vol. 20,8 (2022): 1305-1319. doi:10.1158/1541-7786.MCR-21-0994

Huang, Feng-Ying et al. “Engineered porous/hollow Burkholderia pseudomallei loading tumor lysate as a vaccine.” Biomaterials vol. 278 (2021): 121141. doi:10.1016/j.biomaterials.2021.121141

Huang, Feng-Ying et al. “A recombinant oncolytic Newcastle virus expressing MIP-3α promotes systemic antitumor immunity.” Journal for immunotherapy of cancer vol. 8,2 (2020): e000330. doi:10.1136/jitc-2019-000330

Escorcia, Freddy E et al. “ImmunoPET Predicts Response to Met-targeted Radioligand Therapy in Models of Pancreatic Cancer Resistant to Met Kinase Inhibitors.” Theranostics vol. 10,1 151-165. 1 Jan. 2020, doi:10.7150/thno.37098

Park, Jeong A et al. “Modulating tumor infiltrating myeloid cells to enhance bispecific antibody-driven T cell infiltration and anti-tumor response.” Journal of hematology & oncology vol. 14,1 142. 8 Sep. 2021, doi:10.1186/s13045-021-01156-5

Mao, Ninghui et al. “Oncogenic ERG Represses PI3K Signaling through Downregulation of IRS2.” Cancer research vol. 80,7 (2020): 1428-1437. doi:10.1158/0008-5472.CAN-19-1394

Hoseini, Sayed Shahabuddin et al. “A potent tetravalent T-cell-engaging bispecific antibody against CD33 in acute myeloid leukemia.” Blood advances vol. 2,11 (2018): 1250-1258. doi:10.1182/bloodadvances.2017014373

Bose, Rohit et al. “ERF mutations reveal a balance of ETS factors controlling prostate oncogenesis.” Nature vol. 546,7660 (2017): 671-675. doi:10.1038/nature22820

Park, Jeong A, and Nai-Kong V Cheung. “GD2 or HER2 targeting T cell engaging bispecific antibodies to treat osteosarcoma.” Journal of hematology & oncology vol. 13,1 172. 10 Dec. 2020, doi:10.1186/s13045-020-01012-y

Adams, Elizabeth J et al. “FOXA1 mutations alter pioneering activity, differentiation and prostate cancer phenotypes.” Nature vol. 571,7765 (2019): 408-412. doi:10.1038/s41586-019-1318-9

Zhang, Zeda et al. “Tumor Microenvironment-Derived NRG1 Promotes Antiandrogen Resistance in Prostate Cancer.” Cancer cell vol. 38,2 (2020): 279-296.e9. doi:10.1016/j.ccell.2020.06.005

Ganesh, Karuna et al. “A rectal cancer organoid platform to study individual responses to chemoradiation.” Nature medicine vol. 25,10 (2019): 1607-1614. doi:10.1038/s41591-019-0584-2